Compare stocks

Ambu A/S is a Danish company operating in the medical device industry, primarily involved in the development, manufacturing, and marketing of innovative healthcare solutions. The company's key products include single-use endoscopes, anesthesia devices, and patient monitoring and diagnostic solutions. Ambu was founded in 1937 and is headquartered in Ballerup, Denmark. It is known for its focus on single-use devices, which help reduce the risk of cross-contamination and improve efficiency in hospitals and clinics worldwide. The company's strategic positioning emphasizes innovation in medical technology and a strong commitment to addressing healthcare challenges globally.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio, while the 2026 acquisition of Apogee adds to AbbVie's immunology depth.